Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Скачать или смотреть 💊⚙️ NDCT Rules amended: faster drug trials to boost pharma R&D | 30 Jan 2026

  • SelfStudy: UPSC Prep App
  • 2026-02-02
  • 4
💊⚙️ NDCT Rules amended: faster drug trials to boost pharma R&D | 30 Jan 2026
  • ok logo

Скачать 💊⚙️ NDCT Rules amended: faster drug trials to boost pharma R&D | 30 Jan 2026 бесплатно в качестве 4к (2к / 1080p)

У нас вы можете скачать бесплатно 💊⚙️ NDCT Rules amended: faster drug trials to boost pharma R&D | 30 Jan 2026 или посмотреть видео с ютуба в максимальном доступном качестве.

Для скачивания выберите вариант из формы ниже:

  • Информация по загрузке:

Cкачать музыку 💊⚙️ NDCT Rules amended: faster drug trials to boost pharma R&D | 30 Jan 2026 бесплатно в формате MP3:

Если иконки загрузки не отобразились, ПОЖАЛУЙСТА, НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если у вас возникли трудности с загрузкой, пожалуйста, свяжитесь с нами по контактам, указанным в нижней части страницы.
Спасибо за использование сервиса video2dn.com

Описание к видео 💊⚙️ NDCT Rules amended: faster drug trials to boost pharma R&D | 30 Jan 2026

💊🚀 India is fast-tracking pharma innovation!
The Union Ministry of Health & Family Welfare has notified amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019 to reduce regulatory delays and strengthen India’s clinical research + R&D ecosystem ✅

⚡ What changed first? (Big Relief for Research!)
Earlier, even small quantities of new drugs made for research needed a test licence 🧾
Now, for non-commercial manufacture of small quantities, the test licence is replaced by a prior intimation mechanism—less paperwork, faster research 🧪✅

⚠️ Safety still comes first!
This waiver does NOT apply to high-risk categories:
☣️ Cytotoxic drugs
🚫 Narcotic substances
🧠 Psychotropic substances
These will still need formal licensing due to safety concerns.

⏱️ Approval timelines cut sharply
Where licences are still required, the statutory approval deadline is now:
🕒 90 days → 45 days
That’s a major push for quicker decisions and faster innovation 📈

🌐 Clinical research gets lighter + more digital
✅ Low-risk BA/BE (Bioavailability/Bioequivalence) studies will not need prior approval—only online intimation.
💻 Submissions will be streamlined via NSWS (National Single Window System) and the SUGAM portal for paperless processing—aligned with Jan Vishwas (trust-based governance) 🧾➡️📲

🎯 Why it matters (UPSC Angle):
✅ Ease of Doing Business + regulatory reforms
✅ Public health + innovation ecosystem
✅ Digital governance + single window clearances
✅ Science & Tech policy + pharma sector growth

📲 UPSC Prep? Make Science-Tech + Governance your scoring zone with SelfStudy: UPSC IAS Prep App! 📚✨

Topics like drug regulation, clinical trials, digital governance, ease of doing business are high-value for Prelims + Mains (GS2/GS3) ✅
SelfStudy converts current affairs into UPSC-ready notes + concepts + practice—without overload.

🔗 Install Now ➜ https://linktr.ee/selfstudy.app

💥 Top Features (More Detail):
🗞️ Daily Current Affairs – crisp + explained + UPSC syllabus linkage
📚 Complete GS Coverage – Prelims + Mains + Interview-ready
🧠 Concept Clarity Modules – understand policy changes & their impacts
📝 MCQs + PYQs + Topic Tests – exam-pattern practice with explanations
🔄 Flashcards + Smart Revision – quick recall before exams
🧭 Smart Study Planner – personalised plan + performance insights
🗺️ Maps/Timelines/Revision Boards – visual learning for retention
💬 Community Discussions – peer insights + doubt support
🎯 Structured Learning Path – clarity, direction, confidence

✅ Whether it’s Health Policy, S&T, Polity, Economy, Environment, IR, or GS—
SelfStudy keeps you consistent—Anyone. Anytime. Anywhere. 🌍⏳🚀

#AnyoneAnytimeAnywhere #SelfStudyUPSC #UPSCPrep #CivilServicesExam
#SelfStudyApp #SelfStudyIAS #SelfStudyUPSCIASPrep #SelfStudyCivilServices
#dailycurrentaffairs #UPSC #UPSC2026 #UPSC2027 #UPSCShorts
#NDCTRules #ClinicalTrials #PharmaResearch #DrugRegulation #HealthPolicy
#EaseOfDoingBusiness #DigitalGovernance #NSWS #SUGAM #JanVishwas
#ScienceAndTech #GS2 #GS3 #CurrentAffairs #Prelims #Mains #ExamReady

Комментарии

Информация по комментариям в разработке

Похожие видео

  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]